[go: up one dir, main page]

ZA200701578B - Combination anticancer therapy and pharmaceutical compositions therefore - Google Patents

Combination anticancer therapy and pharmaceutical compositions therefore

Info

Publication number
ZA200701578B
ZA200701578B ZA200701578A ZA200701578A ZA200701578B ZA 200701578 B ZA200701578 B ZA 200701578B ZA 200701578 A ZA200701578 A ZA 200701578A ZA 200701578 A ZA200701578 A ZA 200701578A ZA 200701578 B ZA200701578 B ZA 200701578B
Authority
ZA
South Africa
Prior art keywords
pharmaceutical compositions
anticancer therapy
combination anticancer
combination
therapy
Prior art date
Application number
ZA200701578A
Other languages
English (en)
Inventor
Bauer Jacques Alain
Chiavaroli Carlo
Original Assignee
Om Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Om Pharma filed Critical Om Pharma
Publication of ZA200701578B publication Critical patent/ZA200701578B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/7036—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/212—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA200701578A 2004-07-23 2005-03-10 Combination anticancer therapy and pharmaceutical compositions therefore ZA200701578B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IB2004002378 2004-07-23

Publications (1)

Publication Number Publication Date
ZA200701578B true ZA200701578B (en) 2008-09-25

Family

ID=34958692

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200701578A ZA200701578B (en) 2004-07-23 2005-03-10 Combination anticancer therapy and pharmaceutical compositions therefore

Country Status (10)

Country Link
US (1) US20090214669A1 (xx)
EP (2) EP1773318A1 (xx)
JP (1) JP2008507499A (xx)
KR (1) KR20070065311A (xx)
AU (1) AU2005266106B2 (xx)
CA (1) CA2587019A1 (xx)
MX (1) MX2007002271A (xx)
RU (1) RU2396960C2 (xx)
WO (1) WO2006011007A1 (xx)
ZA (1) ZA200701578B (xx)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA200701578B (en) * 2004-07-23 2008-09-25 Om Pharma Combination anticancer therapy and pharmaceutical compositions therefore
CA2734147A1 (en) * 2008-08-15 2010-02-18 William B. Parker Purine nucleoside phosphorylase as enzymatic activator of nucleoside prodrugs
CN102203132A (zh) * 2008-08-25 2011-09-28 安普利穆尼股份有限公司 Pd-1拮抗剂的组合物和使用方法
US8357652B2 (en) 2009-11-20 2013-01-22 Academia Sinica Anti-tumor fibrillar human serum albumin methods and compositions
UA98665C2 (ru) * 2010-03-25 2012-06-11 Геннадий Васильевич Мазильников Лекарственный препарат, проявляющий противоопухолевое действие в отношении злокачественных клеток, и способ лечения
UA98666C2 (ru) * 2010-03-25 2012-06-11 Геннадий Васильевич Мазильников Лекарственный препарат на основе щавелевой кислоты, проявляющий противоопухолевое действие в отношении злокачественных клеток, и способ лечения
US10585101B2 (en) * 2016-03-10 2020-03-10 Wavesense, Inc. Prostatic liquid biopsy for the detection of prostate cancer and benign prostatic hyperplasia

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3443507A1 (de) * 1984-11-29 1986-06-12 Mückter, Heinrich, Dipl.-Chem. Dr., 5100 Aachen Verwendung von gereinigten lipopolysacchariden und deren derivaten
GR860379B (en) * 1985-02-22 1986-06-11 Akzo Nv Novel disaccharide and trisaccharide derivatives of the lipid a type
US4912094B1 (en) * 1988-06-29 1994-02-15 Ribi Immunochem Research Inc. Modified lipopolysaccharides and process of preparation
EP0668289A4 (en) * 1993-09-07 1998-10-21 Suntory Ltd NEW DISACCHARIDE DERIVATIVE.
JP3967769B2 (ja) * 1993-11-17 2007-08-29 オーエム・ファルマ グルコサミンジサッカライド、それらの製造法、それらを含む医薬組成物およびそれらの使用
WO2001046127A1 (fr) * 1999-12-22 2001-06-28 Om Pharma Pseudodipeptides acyles porteurs d'un bras auxiliaire fonctionnalise
US20020156033A1 (en) * 2000-03-03 2002-10-24 Bratzler Robert L. Immunostimulatory nucleic acids and cancer medicament combination therapy for the treatment of cancer
WO2003079299A2 (en) * 2002-03-18 2003-09-25 Koninklijke Philips Electronics N.V. Holder for papers of value, and method of registering the contents thereof
ZA200701578B (en) * 2004-07-23 2008-09-25 Om Pharma Combination anticancer therapy and pharmaceutical compositions therefore

Also Published As

Publication number Publication date
WO2006011007A1 (en) 2006-02-02
CA2587019A1 (en) 2006-02-02
AU2005266106A1 (en) 2006-02-02
EP1773318A1 (en) 2007-04-18
KR20070065311A (ko) 2007-06-22
MX2007002271A (es) 2007-06-15
US20090214669A1 (en) 2009-08-27
RU2396960C2 (ru) 2010-08-20
AU2005266106B2 (en) 2010-12-09
EP2170318A1 (en) 2010-04-07
JP2008507499A (ja) 2008-03-13
RU2007106845A (ru) 2008-09-10

Similar Documents

Publication Publication Date Title
IL178775A0 (en) Pharmaceutical compositions for acute glucocorticoid therapy
EP1857489A4 (en) MICROPARTICLE AND PHARMACEUTICAL COMPOSITION
EP1765283A4 (en) PHARMACEUTICAL COMPOSITIONS
IL178894A0 (en) Therapeutic antimicrobial compositions and methods
IL178651A0 (en) Pharmaceutical compositions
GB0419849D0 (en) Pharmaceutical combination
IL221323A0 (en) 1-methyl-1h- pyridin-2-one- phenanthridine derivatives and pharmaceutical compositions containing the same
IL183986A0 (en) Pharmaceutical compounds and compositions
IL177168A0 (en) N-sulphonylpyrrole derivatives and pharmaceutical compositions containing the same
IL181730A0 (en) Benzodiazinone derivatives and pharmaceutical compositions containing the same
IL183893A0 (en) Pharmaceutical compositions for the treatment of cellulite
IL178067A0 (en) Pharmaceutical dosage forms and compositions
IL186337A0 (en) Stannsoporfin compositions and administration
PL1803456T3 (pl) Kompozycje farmaceutyczne zawierające L-733060 do zastosowania w leczeniu guzów nowotworowych
ZA200702038B (en) Pharmaceutical composition drospirenone and ethynyle-stradiol
ZA200701578B (en) Combination anticancer therapy and pharmaceutical compositions therefore
EP1805154A4 (en) PHARMACEUTICAL COMPOSITIONS
IL177498A0 (en) Difluoroethoxy -substituted hydroxy-6-phenylphenanthridine derivatives and pharmaceutical compositions containing the same
ZA200700844B (en) Quinolone-containing medicinal composition
IL177497A0 (en) Isoamido-substituted hydroxy-6-phenylphenanthridine derivatives and pharmaceutical compositions containing the same
IL189827A0 (en) Pharmaceutical dosage forms and compositions comprising lecoztan
PT2474528E (pt) Compostos antineoplásicos e composições farmacêuticas dos mesmos
ZA200609685B (en) Pharmaceutical compositions for acute glucocorticoid therapy
EP1813288A4 (en) MEDICAL COMPOSITION, MEDICAL PREPARATION AND COMBINATION PREPARATION
EP1865777A4 (en) STANNSOPORFIN COMPOSITIONS AND ADMINISTRATION